Share This Page
Drug Price Trends for HYOSCYAMINE ER
✉ Email this page to a colleague
Average Pharmacy Cost for HYOSCYAMINE ER
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| HYOSCYAMINE ER 0.375 MG TAB | 62559-0423-01 | 0.90169 | EACH | 2025-05-21 |
| HYOSCYAMINE ER 0.375 MG TAB | 62559-0423-01 | 0.91123 | EACH | 2025-04-23 |
| HYOSCYAMINE ER 0.375 MG TAB | 62559-0423-01 | 0.89906 | EACH | 2025-03-19 |
| HYOSCYAMINE ER 0.375 MG TAB | 62559-0423-01 | 0.88827 | EACH | 2025-02-19 |
| HYOSCYAMINE ER 0.375 MG TAB | 62559-0423-01 | 0.86268 | EACH | 2025-01-22 |
| HYOSCYAMINE ER 0.375 MG TAB | 62559-0423-01 | 0.85838 | EACH | 2024-12-18 |
| HYOSCYAMINE ER 0.375 MG TAB | 62559-0423-01 | 0.85351 | EACH | 2024-11-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Hyoscyamine ER Market Analysis and Price Projections
Market Overview
The global hyoscyamine market, which includes the extended-release (ER) formulation, is experiencing significant growth driven by increasing demand for treatments of gastrointestinal disorders and other therapeutic applications. Here are the key points to consider:
Market Size and Growth
The global hyoscyamine market was valued at approximately $480 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2030[1][3].
Regional Market Dynamics
North America, particularly the United States, is expected to play a pivotal role in the market's development. The region is anticipated to experience considerable growth due to the high adoption of advanced technologies and the presence of major industry players. Europe is also forecasted to see significant growth, while Asia-Pacific, South America, and the Middle East and Africa are expected to contribute to the global market expansion[1][3].
Applications and Types
Hyoscyamine, including its ER formulation, is used in various applications such as hospitals and drug stores. The drug is available in several forms, including oral tablets, injectable solutions, oral liquids, and extended-release tablets. The oral and injectable types are driving the growth of the hyoscyamine market[1][3].
Mechanism of Action and Uses
Hyoscyamine is an anticholinergic that competitively and non-selectively antagonizes muscarinic receptors. It is used to treat functional gastrointestinal disorders, biliary and renal colic, acute rhinitis, and other conditions. The ER formulation is particularly beneficial for providing sustained relief over a longer period[4].
Price Projections
Current Pricing
- Oral Tablet, Extended Release: The cost for hyoscyamine 0.375 mg oral tablet, extended release, is around $34.56 for a supply of 60 tablets, with prices varying depending on the pharmacy and quantity[2].
Future Pricing Trends
Given the projected market growth, prices are likely to be influenced by several factors:
- Demand and Supply: Increasing demand for hyoscyamine due to rising prevalence of chronic diseases and an aging population may lead to higher prices if supply does not keep pace.
- Technological Advancements: The integration of AI and automation in drug development and manufacturing could lead to more efficient production, potentially reducing costs and stabilizing prices[1].
- Competitive Landscape: The presence of multiple manufacturers such as GlaxoSmithKline, Jasper Pharm, Gem Pharmaceuticals, and others may lead to competitive pricing strategies, which could influence the market prices[1][3].
Technological Impact
The integration of AI and automation is significantly reshaping the hyoscyamine market. AI-driven data analysis and predictive modeling are accelerating research and development phases, while automation in manufacturing is improving precision, consistency, and scalability of production. These advancements are expected to boost market growth and innovation, potentially leading to more competitive pricing and better product offerings[1].
Competitive Landscape
The hyoscyamine market is highly competitive with several key players. These include:
- GlaxoSmithKline
- Jasper Pharm
- Gem Pharmaceuticals
- Irza Pharm
- Hoechst
- Lahore Chemical and Pharmaceutical Works
- Genera Pharmaceuticals
- Chen-ho Pharmaceuticals
- Pfizer
- Karo Pharma
- Yung Shin Pharmaceutical
These companies are expected to continue innovating and competing, which could impact pricing strategies and market dynamics[1][3].
Consumer and Patient Impact
For consumers, the cost of hyoscyamine ER can be managed through various discount programs and patient assistance plans. For example, the Drugs.com Discount Card can save patients up to 80% or more off the cost of prescription medicines[2][5].
Market Research and Strategic Planning
Market research reports play a crucial role in strategic planning for businesses in the hyoscyamine market. These reports help in understanding market trends, identifying potential risks, and gaining insights into competitors' strategies. They are essential for investors to make informed decisions and for guiding product development to meet consumer needs and drive business growth[1].
Key Takeaways
- The global hyoscyamine market is projected to grow significantly, driven by increasing demand for gastrointestinal disorder treatments.
- The ER formulation is a key part of this growth, offering sustained relief.
- Technological advancements in AI and automation are enhancing drug development and manufacturing efficiency.
- The market is highly competitive, with multiple key players influencing pricing and innovation.
- Consumer costs can be managed through discount programs and patient assistance plans.
FAQs
What is the current market size of the hyoscyamine market?
The global hyoscyamine market was valued at approximately $480 million in 2022[1].
What is the projected CAGR for the hyoscyamine market from 2023 to 2030?
The market is projected to grow at a CAGR of 5.2% from 2023 to 2030[1].
What are the primary applications of hyoscyamine?
Hyoscyamine is primarily used in hospitals and drug stores for treating various conditions including gastrointestinal disorders, biliary and renal colic, and acute rhinitis[1][3].
How does the extended-release formulation of hyoscyamine benefit patients?
The extended-release formulation provides sustained relief over a longer period, which can be more convenient and effective for patients requiring ongoing treatment[4].
Which regions are expected to lead the growth in the hyoscyamine market?
North America, particularly the United States, and Europe are expected to lead the growth in the hyoscyamine market, with significant contributions from Asia-Pacific, South America, and the Middle East and Africa[1][3].
Cited Sources
- GitHub - Market Report: Hyoscyamine Market
- Drugs.com - Hyoscyamine Prices, Coupons, Copay Cards & Patient Assistance
- Valuates Reports - Hyoscyamine Market
- DrugBank - Hyoscyamine: Uses, Interactions, Mechanism of Action
- Drugs.com - Atropine/hyoscyamine/phenobarbital/scopolamine Prices, Coupons, Copay Cards & Patient Assistance
More… ↓
